Our team

Board of Directors

Luis Sánchez-Lafuente


Former Chief Executive Officer and co-owner of Laboratorios Gelos, SA. President of AB Biotics, SA

Carles Domènech

Executive chairman

Executive Chairman, CSO and co-Founder of Ability Pharmaceuticals, SL


José Manuel Valadés

General secretary

Lawyer, partner and founder of the law firm Alliant Abogados

Miquel Àngel Bonachera

Chief executive officer and co-founder of AB Biotics, SA.
BSc/MSc in biochemistry and MBA.

Sergi Audivert

Chief executive officer and co-founder of AB Biotics, SA. 
BSc/MSc in food technology and MBA.

Sara Secall

Operating Partner & Life Sciences Investment Director of Inveready Asset Management

Santiago Descarrega

Venture Capital Partner at Fitalent (grup Everis)



Press Release

Ability Pharmaceuticals announces the presentation of the phase 2a results of ABTL0812 as first-line therapy in patients with lung cancer at the ASCO 2023 Annual Meeting in Chicago + info

Press Release

AbilityPharma Achieves the 30% of the Estimated Recruitment for their Phase 2b Clinical Trial with ABTL0812 + FOLFIRINOX as a First-Line Therapy Treatment in Advanced Pancreatic Cancer + info

Press Release

AbilityPharma Obtains 1,5M € of Non-Dilutive Funding from Next Generation EU Funds to Further Study the Anticancer Immunomodulatory Effects of ABTL0812 + info

Press Release

AbilityPharma will attend LSX investical showcase in London to meet with key investors and venture capital firms + info

Press Release

ABTL0812 shows potential against glioblastoma brain tumors + info

Press Release

AbilityPharma Secures 2,2M € of Non-Dilutive Funding from the Ministry of Science & Innovation of the Government of Spain to Accelerate the Clinical Development and Regulatory Path of ABTL0812 + info

Press Release

Carles Domènech, Executive Chairman & CEO of AbilityPharma, Will Attend ESMO Congress in Paris for a Meeting with some of the most Relevant Key Opinion Leaders (KOLs) in the Treatment of Pancreatic Cancer + info

Press Release

AbilityPharma Will Attend ESMO World Congress on Gastrointestinal Cancer 2022 in Barcelona + info

Press Release

AbilityPharma Will Attend the ESMO Gynaecological Cancers Congress 2022 in Valencia + info
© 2012 Ability Pharma / All Rights Reserved / Legal Notice / Privacy Police